Question 1

What is the catalog number for Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594]?

Accepted Answer

The catalog number for Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594] is NBP1-74988PEATT594.

Question 2

What sizes are available for Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594]?

Accepted Answer

Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594] is available in the following size(s): 0.5 mL.

Question 3

Is Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594] in stock?

Accepted Answer

Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 5

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Question 6

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Goat Polyclonal Goat anti-Human IgG Fc fragment Secondary Antibody [PE/Atto594]

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

MHC II (HLA-DRA) (19-26.1), CF740 conjugate, 0.1mg/mL

Cdc20 (AR12), CF568 conjugate, 0.1mg/mL

CD68 (C68/684 + KP1), CF740 conjugate, 0.1mg/mL

Lambda Light Chain Mouse Monoclonal Antibody [A8G5]

Cyclin D1 (DCS-6), 0.2mg/mL

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL